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The physiological response to physical exercise is now recognized as an important tool
which can aid the diagnosis and treatment of cardiovascular diseases. This is due to
the fact that several mechanisms are needed to accommodate a higher cardiac output
and a higher oxygen delivery to tissues. The aim of the present work is to provide a fully
closed loop cardiorespiratory simulator reproducing the main physiological mechanisms
which arise during aerobic exercise. The simulator also provides a representation of the
impairments of these mechanisms in heart failure condition and their effect on limiting
exercise capacity. The simulator consists of a cardiovascular model including the left and
right heart, pulmonary and systemic circulations. This latter is split into exercising and
non-exercising regions and is controlled by the baroreflex and metabolic mechanisms.
In addition, the simulator includes a respiratory model reproducing the gas exchange
in lungs and tissues, the ventilation control and the effects of its mechanics on the
cardiovascular system. The simulator was tested and compared to the data in the
literature at three different workloads whilst cycling (25, 49 and 73 watts). The results
show that the simulator is able to reproduce the response to exercise in terms of:
heart rate (from 67 to 134 bpm), cardiac output (from 5.3 to 10.2 l/min), leg blood
flow (from 0.7 to 3.0 l/min), peripheral resistance (from 0.9 to 0.5mmHg/(cm3/s)), central
arteriovenous oxygen difference (from 4.5 to 10.8ml/dl) and ventilation (6.1–25.5 l/min).
The simulator was further adapted to reproduce the main impairments observed in heart
failure condition, such as reduced sensitivity of baroreflex and metabolic controls, lower
perfusion to the exercising regions (from 0.6 to 1.4 l/min) and hyperventilation (from 9.2
to 40.2 l/min). The simulator we developed is a useful tool for the description of the
basic physiological mechanisms operating during exercise. It can reproduce how these
mechanisms interact and how their impairments could limit exercise performance in heart
failure condition. The simulator can thus be used in the future as a test bench for different
therapeutic strategies aimed at improving exercise performance in cardiopathic subjects.
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INTRODUCTION
Physical exercise is associated with an increase in metabolic
activity to which the cardiovascular system responds by
accommodating a cardiac output eightfold its baseline value, or
even higher. Several mechanisms are involved, such as: heart
rate increase, heart contractility improvement, higher venous
return, vascular vasodilation in the exercising regions, deepening
of ventilation pattern (Balady et al., 2010).
In the presence of cardiac pathologies, one or more of these
mechanisms are impaired so that patients experience exercise
intolerance. Even subjects asymptomatic at rest condition,
such as heart failure patients with preserved ejection fraction,
show a reduced exercise performance. For this reason the
exercise test is nowadays recognized to be a valuable diagnostic
tool for the early detection, or the evaluation of a patient’s
cardiac and pulmonary diseases (Balady et al., 2010). Exercise
intolerance in heart failure condition (HF) is the result
of several physiological impairments involving both central
and peripheral mechanisms. HF subjects are characterized
by a compromised Frank-Starling mechanism, an impaired
autonomic and vascular function and a reduced muscular
strength (Mezzani et al., 2009). All these factors reduce exercise
performance and quality of life in comparison to healthy
condition (Healthy).
The analysis of these limiting factors and how they fail to
fully adapt during exercise can greatly benefit from the use of
a dedicated simulator. The simulator has the advantage that it
can provide a quantitative description and a rational cause-effect
relationship of physiological events. As previously stated, exercise
is the result of complex and multifactorial phenomena. Their
representation therefore requires a general cardiorespiratory
model, combined with its main control mechanisms.
Previous simulators modeled exercise physiology (Heldt et al.,
2002; Magosso and Ursino, 2002; Wang et al., 2007) but they
did not include the gas exchange in lungs and tissues nor the
ventilation control. Cardiovascular-respiratory models have been
developed (Batzel et al., 2007; Cheng et al., 2010) but they are not
focused on the representation of physical activity phenomena.
Finally, the HumMod (Hester et al., 2011), a model of integrative
human physiology, provides a representation of the response of
the human body to exercise but its structure is quite complex, as
it has been developed for several other general applications.
A cardiorespiratory simulator specifically developed to
reproduce the basic mechanisms occurring during exercise, and
especially their impairments in HF, could therefore provide an
innovative tool to describe and investigate exercise physiology.
The simulator we present here is a full closed loop
cardiorespiratory system. It was developed and used to reproduce
cycling activity at different workloads in Healthy. The resulting
outputs are discussed in this paper and validated with peer-
reviewed physiological literature.
In addition, we further adapted the simulator to reproduce
the impairments of control mechanisms in HF and the resulting
limited exercise performance. A comparative analysis between
Healthy and HF exercise is presented, finally, in terms of
hemodynamic and respiratory parameters.
MATERIALS AND METHODS
General Overview of the Simulator
The cardiorespiratory simulator is a lumped parameter model
developed in LabVIEW 2014 (National Instrument, Austin, TX,
USA). The overview of all its components is provided in Figure 1,
the interface is shown in Figure 2. Table 1 reports a list of the
main abbreviations used in the text.
Cardiovascular Model
The cardiovascular model was already described in Fresiello et al.
(2013) and Fresiello et al. (2015). Briefly, atria are represented as
passive compliances:
Cla =
dVla(t)
dPla(t)
(1)
Where Cla represents the elastic properties of the left atrium, Vla
and Pla are the left atrial volume and pressure, respectively.
Ventricular contraction is described by the time varying
elastance model (Sagawa et al., 1988):
Plv(t) = Elv(t) ·
(
Vlv(t)− Vlv0
)
(2)
Where Elv is the time varying left ventricular elastance with peak
systolic value Elmax, Vlv0 is the left ventricular zero pressure
filling volume.
Ventricular filling is represented as a sum of exponential
functions:
Plv(t) = al · ebl·Vlv(t) + cl (3)
Where Plv (Vlv) is the left ventricular pressure (volume). The
three parameters a, b and c are estimated to reproduce data from
Carroll et al. (1983). Similar equations were implemented for the
right atrium and ventricle.
The systemic circulation was already presented in Fresiello
et al. (2013). It includes the following sections: ascending aorta,
descending aorta, upper body, kidneys, splanchnic circulation,
left and right legs, superior vena cava, inferior vena cava
inside and outside the chest (see Figure 1). For this latter
a Starling resistor was introduced to reproduce the effect of
ventilation pressures on the collapsible tube (Pedley, 1980).
Venous valves are simulated as simple diodes preventing blood
flowing backward. The pulmonary circulation is split into arterial
and venous sections (see Ferrari et al., 2011 for more details).
The complete list of cardiovascular parameters is reported in
Table 2.
Ventilation Mechanics
The mechanics of the lungs’ function were replicated through a
simplified model taken from Ben-Tal (2006):
Pm− Ppl(t) = R
dVlungs(t)
dt
+ Vlungs(t) · E (4)
Where R is the resistive element of the airways, whose value was
taken from Ben-Tal (2006). E is the elastance element for the
lungs whose value was taken from Cross et al. (2012). Vlungs
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FIGURE 1 | Block diagram of the cardiorespiratory simulator with all its components.
is the lungs volume, Pm is the mouth pressure set equal to the
atmospheric pressure and Ppl is the pleural pressure. The latter
was reproduced with a sinusoidal function:
Ppl(t) = Ppl0 −
E · TV
2
· sin
(
2 · π · Freq
60
· t
)
(5)
Where Freq is the ventilation frequency, TV is the tidal volume
and Ppl0 is a constant parameter that represents the mean value
of Ppl. The intrathoracic pressure (Pintr) is then calculated as
difference between Ppl and the atmospheric pressure and is used
for all the compliances of the cardiovascular system inside the
chest.
Gas Exchange
Gas exchange in the lung compartment is modeled through
a mass balance equation (see Appendix in Supplementary
Material):
(
(VE exp + VA(t))+ 863 · Vap(t) ·
dCO2ap(t)
dPO2alv(t)
)
·
dPO2alv(t)
dt
= 863 ·
(
1− ps
)
· Qpv(t) ·
(
CO2ap(t)− CO2vp(t)
)
+
•
VA(t) · (PO2I − PO2alv(t)) (6)(
(VEinsp + VA(t))+ 863 · Vap(t) ·
dCO2ap(t)
dPO2alv(t)
)
·
dPO2alv(t)
dt
= 863 ·
(
1− ps
)
· Qpv(t) ·
(
CO2ap(t)− CO2vp(t)
)
(7)
Where Vap is the pulmonary arterial volume, VEexp(VEinsp)
is the alveolar volume at the end of expiration (inspiration),
VA is the incremental alveolar volume V˙A is the alveolar
ventilation over time calculated from dVlungs/dt in equation
(4) subtracting the dead space ventilation calculated from
equation (12). Qpv is the pulmonary venous blood flow,
ps is the pulmonary shunt, CO2ap (CO2vp) is the O2
concentration in the arterial (venous) pulmonary blood,
PO2alv (PO2I) is the O2 partial pressure in the alveoli
(inspired air).
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FIGURE 2 | Simulator interface. (A) Shows: the pressure—volume loop of the ventilation system, the O2 and CO2 dissociation curve. Red and blue dots indicate
the arterial and venous pulmonary concentration and partial pressures values. (B) Shows the mean arterial and venous pulmonary flows (Qapm, Qvpm) and the CCO2,
CO2, PO2, and PCO2 in the alveoli. (C) shows the left ventricular pressure—volume loop (left side) and the systemic arterial and left ventricular pressure waveforms
(right side). (D) Shows the right ventricular and pulmonary arterial pressure waveforms (left side) and the right ventricular pressure-volume loop (right side). (E) Shows
the arterial resistance (Ri), the CCO2, CO2, PO2, and PCO2 in the ith vascular compartment. (F) Shows the physical activity regulation button.
We assumed that the blood has enough time to be saturated
while flowing in the pulmonary circulation, therefore O2 and
CO2 partial pressures are equal in the alveoli and in the blood.
This assumption is valid unless we consider extreme levels of
exercise, which is not the aim of the present work.
The O2 and CO2 concentrations in the blood leaving the
lungs are calculated using the dissociation curve developed by
Spencer et al. (1979) and Gólczewski (2010), respectively. The
O2 and CO2 concentrations in the arterial blood are calculated
combining the concentrations of blood leaving the lungs with the
mixed venous blood, according to the ps value.
In the tissue compartment, gas exchange is modeled with a
mass balance equation:
d
(
CO2iv(t) · Vi(t)
)
dt
= CO2ia(t) · Qia(t)− CO2iv(t) · Qiv(t)−
•
VO2i
(8)
Where Qia (Qiv) is the arterial (venous) blood flowing inside
(outside) the ith compartment, CO2ia is the O2 concentration
in the arterial blood stream, CO2iv is the O2 concentration in
the venous blood stream, Vi is the blood volume of the ith
compartment,
•
VO2i is the O2 consumption.
A similar equation was implemented for the CO2 with a
production term that takes into account the respiratory quotient
(RQ).
d
(
CCO2iv(t) · Vi(t)
)
dt
= CCO2ia(t) · Qia(t)− CCO2iv(t) · Qiv(t)+ RQ ·
•
V O2i (9)
We also assume that the diffusion of O2 and CO2 is fast enough
to consider that their concentration in the tissue is equal to the
one in the venous blood.
Ventilation Control
Ventilation control takes the arterial partial pressure of O2 and
CO2 in the upper body (PO2uba and PCO2uba) as input and
provides ventilation (Vent) in l/min as output:
Vent = α · eβ·PO2 uba · (PCO2uba − PCO2tr)+ γ · (PCO2uba − PCO2tr)
(10)
Equation (10) is an adaptation of the ventilation control
developed by Batzel et al. (2007). PCO2tr is a threshold to start a
new ventilation cycle, β is a constant parameter, α and γ are the
ventilation control gains for O2 and CO2, respectively. Parameter
values were estimated by fitting the data reported by Cormack
et al. (1957) and Nunn (1969).
Vent is then expressed as frequency (Freq) and TV :
Freq = δ · Vent + ε (11)
Where δ and ε are constant parameters obtained by fitting data
from seven healthy subjects reported by Weber et al. (1982).
TV can be then calculated as the ratio Vent/Freq and used in
Equation (5).
The effective tidal volume used to calculate alveolar ventilation
will be then:
TVeff = TV · (1− KDV ) (12)
Where KDV is the dead volume ratio that takes into account
the percentage of dead volume of airways. The value of this
parameter was obtained according to the equation reported by
Wasserman et al. (1997): dead space/tidal volume= −0.012·(peak
O2 uptake) + 0.611. We considered a peak O2 uptake of 34 and
15ml/min/Kg for Healthy and HF, respectively.
A list of ventilation parameters is reported in Table 3.
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TABLE 1 | List of abbreviations.
Symbol Abbreviation
CCO2ia/CCO2iv Arterial/venous blood CO2 concentration in the ith compartment
CO2ia/CO2iv Arterial/venous blood O2 concentration in the ith compartment
FO2alv/FO2I Molar fraction of O2 in the alveoli/inspired air
Fas Afferent nerve activity
Fes Sympathetic nerve activity
Fev Vagal nerve activity
Freq Frequency of ventilation
H Generic cardiovascular parameter
Healthy Healthy condition
HF Heart failure condition
HR Heart rate
PCO2i Partial pressure of CO2 in the ith compartment
Pintr Intrathoracic pressure
Pla Left atrial pressure
Plv Left ventricular pressure
Pm Mouth pressure
PO2i Partial pressure of O2 in the ith compartment
Ppl Pleural pressure
Qlla Left leg arterial blood flow
Ri Arterial or venous resistance of the ith compartment
Ria Arterial resistance of the ith compartment
Riv Venous resistance of the ith compartment
RQ Respiratory quotient
sfHs Static function of the sympathetic control for H
sfHv Static function of the vagal control for H
sfRiMet Static function of the metabolic control for Ri
TC Heart cycle duration
TPR Total peripheral resistance
TV Tidal volume
•
V A Alveolar ventilation
Vap Pulmonary arterial volume
Vent Minute ventilation
Vlungs Lungs volume
Vla Left atrial volume
Vlv Left ventricular volume
•
V O2i O2 consumption in the ith compartment
WL Workload
Baroreflex Control
The baroreflex model was taken fromUrsino (1998) and Fresiello
et al. (2013). It provides a representation of the afferent nerve
activity, depending on the pressure sensed in the aortic region.
In addition, the model reproduces the vagal and sympathetic
nerve activity and their effects on cardiovascular parameters. In
the model of Ursino (1998) the pressure in the carotid arteries is
the input the baroreflex control. Since in the present simulator
there is no specific representation of the carotid arteries, the
aortic pressure without the effect of the intrathoracic pressure
was considered as input pressure for the baroreflex control (Paa).
This pressure is used in a linear derivative block:
τp ·
dP(t)
dt
= Paa(t)+ τz ·
dPaa(t)
dt
− P(t) (13)
Where τ p and τ z are the pole and the real zero. The output
variable P(t) has the dimension of a pressure.
To reproduce exercise and the related phenomenon
of baroreflex resetting, the model was further changed.
Three main mechanisms were implemented: the change of
systemic arterial pressure set point PaaSET (strictly related
to the operating point of baroreflex), the progressive
increment of sympathetic activity (Fes), and the vagal (Fev)
withdrawal.
The change of PaaSET was modeled as a function of workload
level (WL):
PaaSET = PaaSET0 + A ·WL (14)
Where PaaSET0 is the set-point pressure at rest condition and A
is the rate of increase of PaaSET per workload unit. Its value was
estimated to reproduce the data reported by Ogoh et al. (2005).
PaaSET0 is used for the calculation of the afferent sympathetic
activity Fas:
Fas(t) =
Fasmin + Fasmax · e
(
P(t)−PaaSET
ka
)
1+ e
(
P(t)−PaaSET
ka
) (15)
Fasmax and Fasmin are constant parameters representing the
upper and lower saturation levels of the Fas function, ka is a
constant parameter related to the slope of Fas at the central point
(obtained for P(t)= PaaSET).
Fas is used to compute the sympathetic nerve activity (Fes):
Fes(t) = Fes∞ + (Fes0 − Fes∞) · e
−kes·Fas(t)
+1Fes (16)
Where Fes0, Fes∞ and kes are constant parameters, 1Fes is the
progressive sympathetic stimulation due to exercise onset. It was
implemented as a function ofWL:
1Fes = B ·WL (17)
Where B is the rate of Fes increase per workload unit. Fas is also
used to compute the efferent vagal activity (Fev):
Fev(t) =
Fev0 + Fev∞ · e
(
Fas(t)−Fas0
kev
)
1+ e
(
Fas(t)−Fas0
kev
) +1Fev (18)
Where Fev∞ is the lower limit of vagal nerve activity, kev is a
constant parameter related to the slope of the function at the
central point (obtained for P(t) = PaaSET). 1fev represents the
vagal nerve activity withdrawal and is expressed as a function of
WL:
1Fev = C ·WL (19)
Where C is the rate of Fev increase per workload unit.
Fev∞ in Equation (19) is the upper limit of vagal nerve activity
and is also expressed as a function ofWL:
Fev∞ = Fev∞0 + D ·WL (20)
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TABLE 2 | List of cardiovascular parameters used for exercise simulation in Healthy condition.
Symbol Parameter Unit Value References
HR Heart Rate bpm 58 Ogoh et al., 2005
Cla/Cra Left/Right atrium compliance cm3/mmHg 25/25 Fresiello et al., 2015
Vlv0/Vrv0 Left/Right ventricular zero pressure volume cm3 5/5
al/ar Left/Right ventricular filling mmHg 0.033/0.05 est. Carroll et al., 1983
bl/br cm−3 0.034/0.04
cl/cr mmHg 8/5
Elmax/Ermax Left/right ventricular elastance mmHg/cm3 2.5/1.1 est. Sullivan et al., 1989
Rli/Rri Left/Right ventricular input resistance mmHg·s/cm3 0.02 Fresiello et al., 2015
Rlo/Rro Left/Right ventricular output resistance mmHg·s/cm3 0.02
Raa Ascending aorta/aortic arch resistance mmHg·s/cm3 0.01
Laa Ascending aorta/aortic arch inertance mmHg·s2/cm3 5.10−5
Caa Ascending aorta/aortic arch compliance cm3/mmHg 0.8
Rabd Descending aorta resistance mmHg·s/cm3 0.07
Labd Descending aorta inertance mmHg·s2/cm3 5.10−5
Cabd Descending aorta compliance cm3/mmHg 0.6
RubaSET Upper body arterial resistance mmHg·s/cm
3 3.52 est. Sullivan et al., 1989
Cub Upper body compliance cm3/mmHg 8 Heldt et al., 2002
RubvSET Upper body venous resistance mmHg·s/cm
3 0.23
Vub0SET Upper body zero pressure volume cm
3 650
RkidaSET Kidney arterial resistance mmHg·s/cm
3 3.62 est. Sullivan et al., 1989
Ckid Kidney compliance cm3/mmHg 15 Heldt et al., 2002
RkidvSET Kidney venous resistance mmHg·s/cm
3 0.3
Vkid0SET Kidneys body zero pressure volume cm
3 150
RspaSET Splanchnic arterial resistance mmHg·s/cm
3 2.69 est. Sullivan et al., 1989
Csp Splanchnic compliance cm3/mmHg 55 Heldt et al., 2002
RspvSET Splanchnic venous resistance mmHg·s/cm
3 0.18
Vsp0SET Splanchnic body zero pressure volume cm
3 1300
RllaSET /RrlaSET Left/Right leg arterial resistance mmHg·s/cm
3 12.6/12.6 est. Sullivan et al., 1989
Cll/Crl Left/Right leg compliance cm3/mmHg 9.5/9.5 Heldt et al., 2002
RllvSET /RrlvSET Left/Right leg venous resistance mmHg·s/cm
3 0.6/0.6
Vll0SET /Vrl0SET Left/Right leg zero pressure volume cm
3 175/175
Csup Superior vena cava compliance cm3/mmHg 15
Rsup Superior vena cava resistance mmHg·s/cm3 0.06
Cinfext/Cinfint Lower vena cava compliance cm3/mmHg 25/2
Rinfext/Rinfint Lower vena cava resistance mmHg·s/cm3 0.01/0.015
Rcp Pulmonary characteristic resistance mmHg·s/cm3 0.03 Ferrari et al., 2011
Cap Pulmonary arterial compliance cm3/mmHg 1
Rap Pulmonary arterial resistance mmHg·s/cm3 0.075 Sullivan et al., 1989
Lap Pulmonary arterial inertance mmHg·s2/cm3 3.6.10−5 Ferrari et al., 2011
Vap0 Pulmonary arterial zero pressure volume cm3 90
Rvp Pulmonary venous resistance mmHg·s/cm3 0.005
Cvp Pulmonary venous compliance cm3/mmHg 5
Vvp0 Pulmonary venous zero pressure volume cm3 580
W Body weight Kg 76 Sullivan et al., 1989
Parameters were taken from literature or estimated (est.) to obtain a good reproduction of literature data.
Where Fev∞0 is the upper limit of Fev at rest, D
is the rate of decrease of Fev∞ so to assure that at
intensive exercise levels, Fev = 0, even at higher pressure
levels.
The parameters in Equations (17), (19), and (20) were
estimated according to the data of Robinson et al. (1966) relative
to the sympathetic and parasympathetic controls of HR in
humans during exercise. In addition, to estimate the parameters
in Equations (19) and (20), we also imposed a nearly complete
vagal withdrawal whenHR reaches 100 bpm during exercise. This
is in agreement with what was reported by Rowell and O’Leary
(1990).
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TABLE 3 | List of parameters used for the ventilation and the muscle contraction models.
Symbol Equations Unit Value (Healthy) Value (HF) References
KDV Dead volume ratio (12) 0.8 0.57 Wasserman et al., 1997
PCO2tr PCO2 threshold for ventilation onset (10) mmHg 36.75 Batzel et al., 2007
E Lungs elastance (4) mmHg/l 2.0 2.8 Cross et al., 2012
PCO2I PCO2 in the inflow air (7) mmHg 0
PIMmax Peak value of PIM per unit of WL (29) mmHg/W 0.562 est. Rådegran and Saltin, 1998
Ppl0 Mean value of Ppl (5) mmHg 754 Ben-Tal, 2006
PO2I PO2 in the inflow air (6) mmHg 150
ps Pulmonary shunt ratio (6)–(7) 0.02 Whiteley et al., 2003
R Airways resistances (4) mmHg/(l/s) 1 Ben-Tal, 2006
α Control gain of ventilation for O2 (10) l/(min·mmHg) 30 est. Cormack et al., 1957; Nunn, 1969
β mmHg−1 −0.055
γ Control gain of ventilation for CO2 l/(min·mmHg) 2
δ Freq to Vent relationship parameters (11) min/l 0.274 est. Weber et al., 1982
ε 17.75
Parameters were taken from literature or estimated (est.) to obtain a good reproduction of literature data.
Fes and Fev are then used to obtain the static sympathetic and
vagal functions (sfHs and sfHv):
sfHs(t) = CHs ·
(
ln(Fes (t − DHs)− FesSET − 1.65)− 1.1
)
(21)
sfHv(t) = CHv · (Fev (t − DHv)− FevSET) (22)
Where DHs (DHv) is the sympathetic (vagal) delay, CHs (CHv) is
the sympathetic (vagal) control gain for the parameter H. FesSET
(FevSET) is the value of Fes (Fev) at the central point (obtained for
Paa= PaaSET).
The final control of the cardiovascular parameter H due to
sympathetic nerve activity will be:
d1Hs(t)
dt
=
sfHs(t) − 1HS
THs
H(t) = HSET +1Hs(t) (23)
Where 1Hs is the change of H due to the sympathetic control,
HSET is the set-point value of H, and THs is the time constant of
the sympathetic control. For the vagal control a similar equation
was implemented.
The model is arranged in such a way that for Paa = PaaSET
the hemodynamic parameters assume their set-point value (H
= HSET). If Paa differs from PaaSET the baroreflex will induce
a change of the hemodynamic parameters. In particular the
sympathetic control will affect the left and right ventricular
contractility, the arterial resistance and the venous tone. For HR
both sympathetic and parasympathetic controls are considered so
that the final regulation will be:
d1TCs(t)
dt
=
sfTCs(t) − 1TCs
TTCs
d1TCv(t)
dt
=
sfTCv(t) − 1TCv
TTCv
(24)
TC(t) = TCSET +1TCs(t)+1TCv(t)
Where TC is duration of a cardiac cycle, TCSET is the set-point
TC, 1TCs, and 1TCv are the changes due to sympathetic and
vagal nerve activity, respectively.
A list of parameters used for baroreflex resetting and control
is reported in Tables 4, 5.
Peripheral Metabolic Control
The metabolic control is a sigmoidal function estimated on the
basis of data observed in human subjects (Pawelczyk et al., 1992;
Calbet, 2006; Heinonen et al., 2013).
sfRiMet(t) = 1−
1
1+ e
kMET ·
(
CO2iv(t)−
CO2 ivRef
2
) (25)
Where CO2iv is the venous oxygen concentration in the ith
circulatory district and CO2ivRef is its reference value taken from
Lanzarone et al. (2007). The static function sfRiMet is then used in
the first order dynamic block that controls the peripheral arterial
and venous resistance of each circulatory district:
d1RiMet(t)
dt
=
CRiMet · (sfRiMet(t)− 1)−1RiMet(t)
TMet
(26)
Where 1RiMet is the change induced by the metabolic control,
TMet is the time constant of the metabolic control. CRiMet is the
control gain estimated from the data reported by Pawelczyk et al.
(1992) and Gonzalez-Alonso et al. (2002). The final control of the
venous resistance of the ith vascular compartment (Riv) will be:
Riv(t) = RivSET +1RivMet(t) (27)
Where RivSET is the set-point value of the venous resistance of ith
vascular district. The metabolic control is arranged in a way that
if CO2iv = CO2ivRef then Riv= RivSET .
The control of the arterial resistances is discussed in the next
paragraph. The list of metabolic control parameters is reported in
Table 5.
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TABLE 4 | List of parameters used for baroreflex model.
Symbol Equations Unit Value (Healthy) Value (HF) References
A Rate of PaaSET increase per unit of WL (14) mmHg/W 0.242 0.3517 est. Ogoh et al., 2005
B Rate of Fes increase per unit of WL (17) spike/(W·s) 0.12 0.02
C Rate of Fev decrease per unit of WL (19) spike/(W·s) −0.041 est. Robinson et al., 1966
D Rate of Fev8decrease per unit of WL (20) spike/(W·s) −0.044 est. Robinson et al., 1966
ka Fas slope parameter (15) mmHg 11.758 Ursino, 1998
kes Fes slope parameter (16) s 0.0675
kev Fev slope parameter (18) spikes/s 7.06
Fes0 Fes upper limit (16) spikes/s 16.11
Fes∞ Fes lower limit (16) spikes/s 2.10
Fev0 Fev lower limit (18) spike/s 3.2
Fev∞0 Fev upper limit at rest (20) spike/s 6.3
PaaSET0 Set point pressure (14) mmHg 90 93 Sullivan et al., 1989
τp Pole (13) s 2.076 Ursino, 1998
τz Zero (13) s 6.37
Parameters were taken from literature or estimated (est.) to obtain a good reproduction of literature data.
Metabolic and Baroreflex Interaction
An important mechanism during exercise is the sympatholysis
which determines the mutual interaction of baroreflex and
metabolic systems in the control of peripheral circulation. The
metabolic control counteracts sympathetic vasoconstriction in
exercising regions, as some local factors and substances reduce
the sensitivity of vascular smooth muscle to sympathetic tone
(Laughlin et al., 2011). To reproduce the sympatholysis effect we
implemented the control of the arterial peripheral resistance as
follows:
Ria(t) = RiaSET · S0 +
[
RiaSET · (1− S0)+1Rias(t)
]
·
sf 10RiMet(t)+1RiaMET (28)
In Equation (28) the metabolic control sfRiMet(t) affects 1Rias(t)
so that when the metabolic vasodilation occurs, the sympathetic
effect also reduces. S0 is a constant parameter that reproduces
the arterial resistance when the sympathetic vasoconstriction
is completely abolished (Pawelczyk et al., 1992; Calbet, 2006;
Heinonen et al., 2013). Its use is discussed in more detail in
paragraph 3.3.1.
Muscle Contraction
Muscle contraction in the exercising regions is represented by a
sinusoidal function. We adapted the one reported by Magosso
and Ursino (2002) to reproduce different levels ofWL.
PIMll(t) = PIMmax ·WL · (1+ sin (2π · t))
PIMrl(t) = PIMmax ·WL · (1+ sin (2π · t + π))
(29)
PIMll and PIMrl are two sinusoidal functions reproducing the
intramuscular pressure of the left and right leg respectively.
Their frequency was set to 1Hz considering a cycling rate of
60 rotations per minute. Their amplitude depends on the value
PIMmax and on the workload set on the bicycle. PIMmax was
estimated on the basis of data reported by Rådegran and Saltin
(1998).
Parameter Assignment
Parameter assignment was performed to characterize the
simulator at rest condition for Healthy and HF. Then, the
exercise was simulated in both conditions and model output was
compared with the data in the literature (see next paragraph).
Cardiovascular parameters were set as reported in Fresiello
et al. (2015). Some parameters were taken from Sullivan et al.
(1989) referring to average data of 12 healthy subjects and of 30
chronic heart failure patients at rest condition, before starting the
exercise test. In particular we set pulmonary resistances, lower
limbs’ and total systemic arterial resistance and the blood volume
on the basis of body weight. A complete list of cardiovascular
parameters for Healthy at rest is reported in Table 2.
To reproduce HF condition we changed the left ventricular
systolic and diastolic functions. The choice of parameter values
was already explained in Fresiello et al. (2015) and will be omitted
here for brevity. Vascular parameters were changed according to
data reported by Sullivan et al. (1989). The complete list of cardiac
and vascular parameters that were changed forHF representation
is reported in Table 6.
Baroreflex sub-model parameters are reported in Tables 4, 5.
Briefly, gain values of the baroreflex control were characterized
as reported in Fresiello et al. (2013). The shift of PaaSET was
reproduced according to the data reported by Ogoh et al. (2005).
Vagal withdrawal parameters were estimated to reproduce data
from Rowell and O’Leary (1990) and Robinson et al. (1966). The
sympathetic stimulation parameters were estimated in order to
reproduce the data reported by Robinson et al. (1966).
For HF condition the sympathetic stimulation parameters
were obtained fitting the data from Sullivan et al. (1989).
The metabolic control function was set so as to obtain a good
reproduction of the data in the literature (Pawelczyk et al., 1992;
Calbet, 2006; Heinonen et al., 2013). These data refer to the
mere metabolic control of peripheral resistance during exercise
in the absence of a sympathetic effect. CO2ivRef in Healthy was set
according to Lanzarone et al. (2007). For the HF we considered
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TABLE 5 | List of parameters used for the sympathetic (symp), vagal (vag), and metabolic (met) controls.
Symbol Equations Unit Value (Healthy) Value (HF) References
CTCs TC symp control gain (21) s/(spikes/s) −0.09 −0.0594 Ursino, 1998 (Healthy)
CTCv TC vag control gain (22) s/(spikes/s) 0.07 0.0462 est. Ogoh et al., 2005 (HF )
CElmaxs Elmax symp control gain (21) (mmHg/cm
3)/(spikes/s) 0.61 0.2 est. Fresiello et al., 2014
CErmaxs Ermax symp control gain (21) (mmHg/cm
3)/(spikes/s) 0.133 0.133
CRubas Ruba symp control gain (21) (mmHg·s/cm
3)/(spikes/s) 1.16 1.62
CRkidas Rkida symp control gain (21) (mmHg·s/cm
3)/(spikes/s) 1.10 1.53
CRspas Rspa symp control gain (21) (mmHg·s/cm
3)/(spikes/s) 0.95 1.32
CRllas Rlla symp control gain (21) (mmHg·s/cm
3)/(spikes/s) 2.4 4.06
CRrlas Rlra symp control gain (21) (mmHg·s/cm
3)/(spikes/s) 2.4 4.06
CRubaMet Ruba met control gain (26) mmHg·s/cm
3 0.73 est. Pawelczyk et al., 1992;
Calbet, 2006; Heinonen et al.,
2013
CRkidaMet Rkida met control gain (26) mmHg·s/cm
3 0.69
CRspaMet Rspa met control gain (26) mmHg·s/cm
3 0.6
CRllaMet Rlla met control gain (26) mmHg·s/cm
3 1.5
CRrlaMet Rlra met control gain (26) mmHg·s/cm
3 1.5
CRubvMet Rubv met control gain (26) mmHg·s/cm
3 0.046
CRkidvMet Rkidv met control gain (26) mmHg·s/cm
3 0.06
CRspvMet Rspv met control gain (26) mmHg·s/cm
3 0.036
CRllvMet Rllv met control gain (26) mmHg·s/cm
3 0.12
CRrlvMet Rlrv met control gain (26) mmHg·s/cm
3 0.12
CVub0s Vub0 symp control gain (21) cm
3/(spikes/s) −28.1 −28.1 est. Fresiello et al., 2014
CVkid0s Vkid0 symp control gain (21) cm
3/(spikes/s) −6.5 −6.1
CVsp0s Vsp0 symp control gain (21) cm
3/(spikes/s) −228.3v −228.3
CVll0 Vll0 symp control gain (21) cm
3/(spikes/s) −7.8 −7.8
CVrl0 Vlr0 symp control gain (21) cm
3/(spikes/s) −7.8 −7.8
CO2ubvRef Reference value for CO2ubv (25) ml O2/dl blood 14 12 Healthy: Lanzarone et al., 2007
HF: est. Sullivan et al., 1989
CO2kidvRef Reference value for CO2kidv (25) ml O2/dl blood 17.5 15.5
CO2spvRef Reference value for CO2spv (25) ml O2/dl blood 15 13
CO2llvRef Reference value for CO2llv (25) ml O2/dl blood 14 12
CO2rlvRef Reference value for CO2lrv (25) ml O2/dl blood 14 12
kMET sfRiMet slope parameter (25) dl blood/ml O2 1.8 est. Pawelczyk et al., 1992;
Calbet, 2006; Heinonen et al.,
2013
S0 Ratio of basal arterial resistance (28) 0.27
TMET Time constant met control (26) s 2 Lanzarone et al., 2007
TElmax Time constant Elmax symp control (23) s 8 Ursino, 1998
TErmax Time constant Ermax symp control (23) s 8
TRis Time constant Ri symp control (23) s 6
TTCs Time constant TC symp control (23) s 2
TTCv Time constant TC vag control (23) s 1.5
TVis Time constant Vi symp control (23) s 20
a lower CO2ivRef at rest, as reported in Sullivan et al. (1989). The
complete list of metabolic parameters is provided in Table 5. The
sympatholysis function described in Equation (28) was estimated
on the basis of data from Pawelczyk et al. (1992) and Gonzalez-
Alonso et al. (2002) referring to both sympathetic and metabolic
control during exercise.
Ventilation control parameters were obtained by fitting data
from Cormack et al. (1957) and Nunn (1969). Parameters relative
to ventilation frequency and tidal volume in Equation (11) were
estimated by fitting data fromWeber et al. (1982).
Validation Procedure
After the assignment of parameters at rest, we simulated graded
bicycle exercise from rest to 73 watts. To reproduce Healthy
exercise we fed the simulator with increasing levels of oxygen
consumption:
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TABLE 6 | List of cardiovascular parameters used for exercise simulation
in HF condition.
Symbol Unit Value References
HR bpm 85 Sullivan et al., 1989
Elmax mmHg/cm3 1.5 Fresiello et al., 2015
Vlv0 cm3 25
al mmHg 0.031
bl cm−3 0.031
cl mmHg 8
RubSET mmHg·s/cm
3 4.72 Sullivan et al., 1989
RkidaSET mmHg·s/cm
3 4.88
RspaSET mmHg·s/cm
3 3.62
RllaSET mmHg·s/cm
3 8.52
RrlaSET mmHg·s/cm
3 8.52
Rap mmHg·s/cm3 0.175
Parameters were taken from literature or estimated (est.) to obtain a good reproduction
of literature data.
•
V O2RR = 196 (30)
•
V O2ll =
•
V O2rl = 5.87 ·WL+ 20.23 (31)
Where
•
V O2RR is resting regions O2 uptake,
•
V O2ll (
•
V O2rl) is left
(right) leg O2 uptake expressed as function of workloads. VO2RR
is divided among all resting circulatory branches as follows: 30%
for the upper body, 32% for kidney and 38% for splanchnic
circulation.
For the RQ we used the following formula:
RQ = 0.0014 ·WL+ 0.859 (32)
A similar procedure was performed for
•
V O2RR,
•
V O2ll (
•
V O2rl) and
RQ in HF:
•
VO2RR_HF = 2.76 ·WL+ 201.06 (33)
•
VO2ll_HF =
•
VO2rl_HF = 3.83 ·WL+ 28.87 (34)
RQ_HF = 0.006 ·WL+ 0.877 (35)
HF is characterized by lower values of oxygen uptake in both
exercising and resting regions and by an earlier anaerobic
metabolism in comparison to Healthy.
Equations (30) to (35) were obtained by interpolating data
from Sullivan et al. (1989).
To reproduce the exercise we initially set the simulator at rest
condition and we left the simulator free to evolve and reach the
steady condition at 24.5 watts, 49 watts and 73 watts. For each
exercise step data were then averaged over 15 heart cycles and
reported as mean values. Simulations were then compared to the
exercise test data from Sullivan et al. (1989) concerning isokinetic
cycling with a graded workload of+24.5 watts/3min.
RESULTS
Sub-Models
This first part of the results’ section is devoted to further
illustrating some of the sub-models described in the methods
section. We focus on baroreflex, metabolic and ventilation
controls.
Figure 3 shows the “baroreflex resetting” described in
Equations (13) to (22). We simulated the stimulus-response
curve of the baroreflex model in an open-loop configuration,
by imposing an aortic pressure ranging from 0 to 200mmHg.
We repeated this procedure at rest condition at three different
exercise levels (35, 61, and 87 watts). Figure 3A shows the
progressive increase of PaaSET described in Equation (14) and the
relative effects on Fas as described in Equation (15). Figure 3B
shows the progressive vagal withdrawal with the increasing of
the exercise level described in Equations (18)−(20). The effect of
vagal withdrawal on HR is shown in Figure 3C. We obtained an
increment ofHR of+28 bpm (from 57 to 85 bpm), similar to the
average increase of +36 bpm reported by Robinson et al. (1966).
Figure 3D shows the sympathetic stimulation for increasing
levels of exercise as described in Equations (16) and (17). The
related effects on HR are shown in Figure 3C. We obtained an
average HR increase of +18 bpm (from 58 to 66 bpm), similar to
the increase of +16 bpm reported by Robinson et al. (1966). The
final control of HR, obtained by combining both Fes and Fev, is
shown in Figure 3F. Model results are compared with the data in
the literature fromOgoh et al. (2005) relative to rest, 31 watts and
85 watts conditions.
Figure 4 provides a comparison between model results and
the data in the literature for the metabolic control. Figure 4A
shows a comparison between the model we implemented and the
data of Pawelczyk et al. (1992), Calbet (2006) and Heinonen et al.
(2013). These data refer to the metabolic control during exercise
with a complete suppression of sympathetic vasoconstriction. To
reproduce these data we removed the sympathetic contribution
to peripheral resistance in Equation (28), obtaining Ria(t) =
RiaSET · S0 +1RiaMET .
Figure 4B shows a comparison between simulation results
and the data in the literature taken from Pawelczyk et al. (1992)
and Gonzalez-Alonso et al. (2002). These data refer to the
systemic resistance regulation during exercise in the presence of
both metabolic and sympathetic controls. Results show that for
CO2iv = CO2ivRef no changes of resistances are observed, for CO2iv
< CO2ivref a vasodilation is induced by the metabolic control.
Figure 5 shows the ventilation control as implemented in
Equation (10). Figure 5A shows the ventilation as a function of
PO2 for two constant values of PCO2. Simulations were repeated
at rest condition and at WL = 73 watts and compared with data
from Cormack et al. (1957). Figure 5B shows the ventilation as
a function of PCO2 for two constant values of PO2. In this case
also, simulations were repeated at rest condition and atWL= 73
watts, and results were compared with data from Nunn (1969).
Exercise Data
In this second part of the results’ section the output of the
cardiovascular simulator for graded exercise is shown.
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FIGURE 3 | Results of the baroreflex resetting model for different levels of physical activity. Dots represent baroreflex central point (for Paa = PaaSET ). (A)
Fas as a function of aortic pressure in a baroreflex open loop configuration. (B) Progressive vagal withdrawal for increasing levels of exercise. (C) Effects of vagal
withdrawal on HR. (D) Progressive sympathetic stimulation for increasing levels of exercise. (E) Effects of sympathetic stimulation on HR. (F) Overall effects of
baroreflex resetting (both Fev and Fes) on HR, comparison between simulations data (continuous line) and the data () from Ogoh et al. (2005).
FIGURE 4 | Metabolic control of peripheral resistance. (A) Percentage change of the peripheral resistance due to a change in venous oxygen concentration
during exercise in the absence of a sympathetic control. Comparison between simulations output and the data from Pawelczyk et al. (1992) and Gonzalez-Alonso
et al. (2002). (B) Percentage change of the peripheral resistance due to a change in venous oxygen concentration during exercise in presence of sympathetic control.
Comparison between simulations output and the data from Pawelczyk et al. (1992), Calbet (2006) and Heinonen et al. (2013).
Figures 6, 7 show simulation results for both Healthy and HF
at rest, at a workload of 24.5, 49, and 73 watts. In the text we will
refer only to results at rest and at 73 watts, for brevity.
Due to baroreflex resetting HR increases for both Healthy
(67–134 bpm) and HF (85–137 bpm). Total peripheral
resistance decreases from 0.9 to 0.5mmHg/(cm3/s) in Healthy
and from 1.2 to 0.6mmHg/(cm3/s) in HF. This is mainly
due to the vasodilation of the lower limbs induced by the
metabolic control. Single leg resistance, in fact, decreases
from 6.5 to 1.0mmHg/(cm3/s) for Healthy and from 8.7 to
1.6mmHg/(cm3/s) for HF.
All these phenomena contribute to accommodating a higher
CO during exercise: from 5.3 to 10.2 l/min in Healthy and from
4.4 to 6.6 l/min in HF. This increase is mostly addressed to better
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FIGURE 5 | Left panel: ventilation over PO2 for two constant values of PCO2(41 and 45mmHg). Comparison between literature (Cormack et al., 1957) and model
data. Right panel: ventilation over PCO2 for two constant values of PO2(40 and 90mmHg). Comparison between model output and the data from Nunn (1969) and
model output.
perfuse the legs. Single leg blood flow increases both in Healthy
(0.7–3.0 l/min) and inHF (0.6–1.4 l/min). In terms of percentage,
the flow of both legs is 26% of CO at rest and 59% during exercise
in Healthy. For HF blood flow is 25% at rest and 42% during
exercise.
The change in TPR and in CO also affects mean systemic
arterial pressure (MAP): we observe an increment of MAP in
Healthy (92–134mmHg) while forHF, pressure attains at a rather
constant value.
Figure 7 also provides some data about the ventilation section.
The increment of oxygen uptake is reflected in the central
arteriovenous oxygen difference that rises from 4.5ml/dl to
10.8ml/dl in Healthy and from 5.9 to 14.4ml/dl in HF. Lower
limbs show the highest augmentation in arteriovenous oxygen
difference: from 3.1 to 15.1ml/dl in Healthy and 5.3–19.2ml/dl
in HF.
Ventilation data are shown in Figure 8. In Healthy condition,
ventilation increases from 6.1 to 25.5 l/min (Figure 8A), and
in HF an even higher increase is observed (9.2–40.2 l/min,
Figure 8B).
The change of ventilation pattern from rest to exercise is
shown in Figure 8C. During exercise ventilation raises with a
consequent increase of tidal volume and a deepening of Pintr
during inspiration.
Themechanical effect of ventilation on venous return is shown
in Figure 8D. During inspiration Pintr decreases thus improving
venous return, the opposite effect is observed during expiration.
DISCUSSION
The cardiorespiratory simulator is composed of a cardiovascular
model (Fresiello et al., 2015) integrated with respiratory and
gas exchange models. Exercise was simulated by augmenting O2
uptake in specific regions, differentiating among exercising and
non-exercising ones. Three regulations were implemented: the
baroreflex, the metabolic and the ventilation controls.
The simulator shares some aspects with the one developed
by Magosso and Ursino (2002): it provides a representation of
exercise and resting vascular regions, baroreflex and metabolic
regulations and the effect of muscle contraction on venous
pressure.
The present work includes all these mechanisms plus
some others. As we wanted to reproduce HF condition, we
implemented amore sophisticated cardiovascular system, further
developing some of the elements introduced by Magosso
and Ursino (2002). In addition, we included the effect,
gas exchange and the ventilation control that permitted the
simulation of respiratory patterns and local arteriovenous oxygen
differences.
The simulator does not provide a description of the overall
human physiology (as in the case of Hester et al., 2011), but
focuses only on those mechanisms that play a key role in
exercise performance. This reduces the complexity of the overall
structure, minimizing the number of equations and parameters.
Such a simplification makes the simulator more easily adaptable
for future research aimed at representing patients’ specific
conditions. An example of model personalization was already
developed for the cardiovascular system and presented in
Fresiello et al. (2015). As a future application, the proposed
simulator will be used to reproduce a patient’s specific
hemodynamic and ventilation status, both at rest and exercise
conditions.
The simulator reproduces the main cardiorespiratory changes
observed during exercise for both Healthy and HF. The latter
required a new parameter assignment for the cardiovascular,
respiratory, baroreflex, and metabolic sub-models.
For HF we simulated a systolic impairment by reducing
the Elmax parameter. The diastolic impairment, typical in
chronic heart failure, was introduced by changing the filling
characteristic. We also reproduced systemic and pulmonary
hypertension by increasing the corresponding resistances (see
Table 6 for more details).
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FIGURE 6 | Comparison between simulations output (light gray) and the data (light gray) from Sullivan et al. (1989). Left panels refer to healthy condition
and right panels to heart failure condition. From (A) to (H): heart rate (HR), mean arterial pressure (MAP), total cardiac output (CO), single leg flow (Qlla).
For the baroreflex resetting we implemented the change
of set-point pressure, the sympathetic overstimulation and
the vagal withdrawal. All these mechanisms provoke heart
chronotropy and inotropy and vasoconstriction for concurrent
increasing values of aortic pressure. For HF the inotropic effect
of baroreflex is less pronounced, since ventricular scar tissue
has no capability to improve its contractility. This effect was
simulated with a reduced sympathetic control gain on Emaxl (see
Table 5, parameter CElmaxs). As a consequence, left ventricular
contractility increases less in HF (1.5–1.7mmHg/cm3) than
in Healthy (2.5–2.9mmHg/cm3). Baroreflex also regulates the
amount of blood stored in venous vessels thus contributing
to the augmentation of cardiac output. During exercise, the
sympathetic nervous system provokes a splanchnic arteriolar
vasoconstriction and reduces venous capacity. As a result, a
certain amount of blood is transferred from the splanchnic region
to the large vessels and then to the heart (Laughlin et al., 2011).
This mechanism was represented in our simulator through the
sympathetic control of venous tone (Vsp0). As a final result we
obtained a blood shift from the splanchnic region to the rest of
the circulation of 287 cm3 in Healthy and of 206 cm3 in HF.
The increase in oxygen uptake lowers venous oxygen
content such that the arteriovenous oxygen difference increases
(see Figures 7E–H). This triggers the metabolic vasodilation
especially in the exercising regions, where more blood needs to
be supplied. The metabolic control shows a different behavior
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FIGURE 7 | Comparison between simulations output (light gray) and data (dark gray) from Sullivan et al. (1989). Left panels refer to healthy condition and
right panels to heart failure condition. From (A) to (H): total peripheral resistance (TPR), single leg resistance (Rlla), central arteriovenous oxygen difference, leg
arteriovenous oxygen difference.
in Healthy and HF. In HF patients in fact, the chronic exposure
of peripheral vessels to lower oxygen saturations makes the
metabolic control less efficient.We reproduced this phenomenon
by simply setting a lower CO2ivRef in HF. This resulted in a
reduced vasodilation during exercise, a lower perfusion, and
higher arteriovenous oxygen difference in the exercising regions
(see Figures 6H, 7D–H).
We also reproduced the sympatholysis effect, so that when
a circulatory district exhibits a higher metabolic activity, the
sensitivity of this region to sympathetic control is reduced.
The interaction of sympathetic and metabolic regulations is
fundamental for blood pressure and CO. The sympathetic
outflow evokes peripheral vasoconstriction preventing a
hypotension phenomenon, while the metabolic control improves
perfusion where it is needed. The balance between these two
mechanisms determines the final value of total peripheral
resistance and the repartition of CO between exercising and
non-exercising regions. Blood flow in the resting end organs is
different between Healthy and HF: it stays rather constant in
Healthy (4.0–4.2 l/min) and increases in HF (3.3–3.8 l/min).
The reason for this opposite phenomenon, penalizing legs
perfusion in HF, lies in the different regulation of peripheral
resistances in resting regions. Combining upper body, kidneys
and splanchnic districts we obtain an overall resistance at
rest of 1.2mmHg·s/cm3 for Healthy and 1.6mmHg·s/cm3
for HF. At exercise we observe a vasoconstriction in Healthy
(1.6mmHg·s/cm3) while a slight vasodilation is observed for HF
(1.4mmHg·s/cm3).
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FIGURE 8 | (A,B) Comparison between simulations output (light gray) and data (dark gray) from Sullivan et al. (1989). Data refer to ventilation in Healthy and HF
conditions. (C,D) Pressure volume loop of the ventilation system at rest and at 24–48–73 watts of workload. Lower right panel: example of the effect of the
intrathoracic pressure profile (Pintr) on mean venous return (Qvm).
From the model’s point of view, this difference might reside in
the lower central arteriovenous oxygen difference observed inHF
during exercise (Figures 7E,F). This might have strengthened the
metabolic vasodilation response of resting regions, preventing
the sympathetic vasoconstriction from reducing oxygen supply.
Similarly (Sullivan et al., 1989) report that HF patients, suffering
from a low perfusion already at rest, show an increase of resting
regions’ blood flow to avoid possible ischemia in vital organs.
Some other differences between Healthy and HF are also
observed at the different respiratory levels. HF shows a higher
ventilation already at rest condition (6.1 l/min for Healthy
and 9.2 l/min for HF). This difference increases even further
with exercise (25.5 l/min for Healthy and 40.2 l/min for HF).
The higher ventilation response in HF is the result of the
increased RQ and of the reduced perfusion of ventilated lungs
(Wasserman et al., 1997). The first phenomenon is due to the
buffering of the accumulated lactic acid during exercise. Its
representation goes beyond the aim of the present work but
Equations (31) and (34) permit some consideration of this effect
(RQ = 1.32 for HF and RQ = 0.96 for Healthy at WL = 73
watts). The reduced perfusion of ventilated lungs in HF was
reproduced with a higher dead volume of the airways. This
parameter was quantified according to Wasserman et al. (1997)
reporting data of both healthy and heart failure subjects. Finally,
the higher lungs elastance used for HF simulations, permitted
to mimic an increased resistance to volume expansion. As a
consequence, in HF a wider change of intrathoracic pressure
is needed to obtain similar tidal volumes of Healthy (see
Figure 8C).
With regard to the quality of simulations, we obtained a good
match between our results and the data in the literature. The
highest error was observed for legs parameters in both Healthy
and HF. This discrepancy is due to a different value of the
initial resistance at rest fed to the simulator (estimated from total
peripheral resistance as reported in Fresiello et al., 2015), and the
one of Sullivan et al. (1989). The difference between simulated
and literature legs arteriovenous O2 difference (see Figure 7H)
at WL = 73 is probably due to the anaerobic effect which was
not taken into account as it goes beyond the scope of the present
work.
In HF condition, all the phenomena described above and
the relative impairments lead to a reduced capability to increase
cardiac output adequately and to provide a sufficient perfusion to
the exercising regions.
The present simulator can reproduce exercise capacity in
Healthy and the basic pathophysiological mechanisms, limiting
exercise capacity in HF. As a next step the simulator will be used
to reproduce some diseases such as valve insufficiency, anemia,
muscle tone impairment, chronotropic incompetence etc. The
simulator will be used to evaluate how these diseases impair
exercise and its related hemodynamic and ventilation parameters.
The simulator will be used also to reproduce some therapies
used in heart failure condition (i.e., medication, ventricular assist
devices) and predict their effects on exercise capacity.
Frontiers in Physiology | www.frontiersin.org 15 June 2016 | Volume 7 | Article 189
Fresiello et al. Cardiorespiratory Model of Aerobic Exercise
STUDY LIMITATIONS
The present simulator provides an overview of the main
mechanisms occurring during aerobic exercise. Some
simplifications were introduced to the model, as explained
below.
At present the mechanisms leading to baroreflex resetting
at the afferent level and their mutual interaction are not
completely understood (Bevegård and Shepherd, 1996; Potts and
Mitchell, 1998). The authors therefore implemented the resetting
phenomenon directly at the efferent level.
The metabolic control model does not take into account
the effects of different metabolites (other than hypoxia)
on vasodilation during exercise (Pawelczyk et al., 1992). A
more detailed metabolic control could better reproduce the
arteriovenous oxygen difference in the legs for higher levels of
exercise in HF, when anaerobic exercise occurs.
The model of pulmonary circulation is rather simple and
does not include O2 and CO2 effects on vascular tone. Its
simple structure permits an easy match with the implemented
respiratory system which is also a simplified version including
only one chamber, with no gravity ventilation-perfusion
mismatch effect. Further improvements need to be implemented
in order to get better simulation results, especially in terms of
ventilation at higher levels of exercise.
CONCLUSIONS
The proposed simulator permits the reproduction of the main
physiological phenomena occurring during exercise at the level
of cardiocirculatory and respiratory systems:
• cardiac output increase and its distribution among exercising
and non-exercising regions,
• increase of heart activity and of vascular tone due to baroreflex
resetting,
• peripheral resistance changes as a result of the combination of
metabolic and baroreflex controls,
• central and local arteriovenous oxygen difference,
• increase of ventilation due to O2 and CO2 partial pressure
changes during exercise.
Moreover, the simulator can reproduce heart failure condition,
the related impairment of control mechanisms and their effects
on exercise performance. The present simulator is suitable for
such future applications as the representation of end-stage heart
failure patients and the impact of therapies (such as drugs and
ventricular assist devices) on their exercise performance.
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